Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

12.05p
   
  • Change Today:
    -0.45p
  • 52 Week High: 40.00p
  • 52 Week Low: 7.45p
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 192,849
  • Market Cap: £36.61m
  • RiskGrade: 479

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
96.18% above the market average96.18% above the market average96.18% above the market average96.18% above the market average96.18% above the market average
86.21% above the sector average86.21% above the sector average86.21% above the sector average86.21% above the sector average86.21% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
4.60% above the market average4.60% above the market average4.60% above the market average4.60% above the market average4.60% above the market average
21.74% below the sector average21.74% below the sector average21.74% below the sector average21.74% below the sector average21.74% below the sector average
Price Book Ratio
72.27% below the market average72.27% below the market average72.27% below the market average72.27% below the market average72.27% below the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
97.21% above the market average97.21% above the market average97.21% above the market average97.21% above the market average97.21% above the market average
91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average
Price Chg 3m
77.98% above the market average77.98% above the market average77.98% above the market average77.98% above the market average77.98% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
74.13% above the market average74.13% above the market average74.13% above the market average74.13% above the market average74.13% above the market average
65.85% above the sector average65.85% above the sector average65.85% above the sector average65.85% above the sector average65.85% above the sector average
Momentum 20
47.97% above the market average47.97% above the market average47.97% above the market average47.97% above the market average47.97% above the market average
56.10% above the sector average56.10% above the sector average56.10% above the sector average56.10% above the sector average56.10% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
0.09% above the market average0.09% above the market average0.09% above the market average0.09% above the market average0.09% above the market average
51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
17.86% below the market average17.86% below the market average17.86% below the market average17.86% below the market average17.86% below the market average
53.49% above the sector average53.49% above the sector average53.49% above the sector average53.49% above the sector average53.49% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.31% below the market average35.31% below the market average35.31% below the market average35.31% below the market average35.31% below the market average
17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average
Operating Profit Loss
6.63% below the market average6.63% below the market average6.63% below the market average6.63% below the market average6.63% below the market average
58.14% above the sector average58.14% above the sector average58.14% above the sector average58.14% above the sector average58.14% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
32.81% below the market average32.81% below the market average32.81% below the market average32.81% below the market average32.81% below the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average
Cash
6.49% below the market average6.49% below the market average6.49% below the market average6.49% below the market average6.49% below the market average
23.81% above the sector average23.81% above the sector average23.81% above the sector average23.81% above the sector average23.81% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
25.19% below the market average25.19% below the market average25.19% below the market average25.19% below the market average25.19% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Buys 1y
22.37% above the market average22.37% above the market average22.37% above the market average22.37% above the market average22.37% above the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
66.28% above the market average66.28% above the market average66.28% above the market average66.28% above the market average66.28% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 12.05p
Change Today -0.45p
% Change -3.60 %
52 Week High 40.00p
52 Week Low 7.45p
Volume 192,849
Shares Issued 303.83m
Market Cap £36.61m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.25% below the market average55.25% below the market average55.25% below the market average55.25% below the market average55.25% below the market average
6.98% above the sector average6.98% above the sector average6.98% above the sector average6.98% above the sector average6.98% above the sector average
Price Trend
86.44% below the market average86.44% below the market average86.44% below the market average86.44% below the market average86.44% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Income Not Available
Growth
25.93% above the market average25.93% above the market average25.93% above the market average25.93% above the market average25.93% above the market average
26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 05-Aug-2025

Time Volume / Share Price
16:35 4,944 @ 12.05p
16:35 3,708 @ 12.05p
16:35 1,125 @ 12.05p
16:35 111 @ 12.05p
16:06 16,637 @ 12.00p

Futura Medical Key Personnel

Finance Director Angela Hildreth

Top of Page